Yozlem Chalashkan

发表

Development of [225Ac]Ac-PSMA-I&T for Targeted Alpha Therapy According to GMP Guidelines for Treatment of mCRPC

Y. Seimbille, F. Bruchertseifer, E. de Blois, 2021, Pharmaceutics.